Wegovy Tablet — oral semaglutide UK — The Weight Clinic Skip to content
The Weight Clinic
Prescription-only medicine · available only after a clinical consultation with our prescriber
In stock now · discreet, tracked next-day delivery · the same medicine as the Wegovy injection, in a daily tablet
HomeTreatmentsWegovy Tablet
Oral GLP-1 weight-loss tablet

Wegovy, now in a tablet.

Medically reviewed by Ali Al Sibahi, Pharmacist Independent Prescriber (GPhC 2225108) · Last reviewed June 2026

The Wegovy Tablet is Novo Nordisk's oral form of semaglutide, the same active medicine as the Wegovy injection, taken as a once-daily tablet instead of a weekly injection. We prescribe it only after a full clinical review with our specialist weight-loss prescriber, and dispense from our own in-house pharmacy.

Active ingredientSemaglutide
AdministrationOnce-daily tablet
Dose range1.5mg – 25mg
From£115 / month
Check if you're eligible
✓ Free consultation✓ UK-registered clinician✓ Full refund before dispatch
Wegovy Tablet — oral semaglutide tablet (Novo Nordisk)
Specialist video consult
A clinician reviews and approves you before anything is dispensed
No needles, no injecting
A simple once-daily tablet — the same GLP-1 medicine, in a different form
How it works

The same medicine, in a daily tablet.

Semaglutide is the active ingredient in both the Wegovy Tablet and the Wegovy injection. It is a GLP-1 receptor agonist — it mimics a natural gut hormone that helps regulate appetite, slows stomach emptying so you feel fuller for longer, and improves blood-sugar control after eating.

Because semaglutide is a protein that would normally be broken down in the gut, the tablet uses an absorption enhancer (the same SNAC technology as Rybelsus) so the medicine can be absorbed. For this to work, the tablet is taken first thing on an empty stomach with a small sip of plain water, then you wait at least 30 minutes before eating, drinking anything else, or taking other medicines. Taken with food it is far less effective.

The Wegovy Tablet is MHRA-approved for weight management in adults with obesity, or overweight with a related health condition. It is a prescription-only medicine and must be prescribed by a UK-registered clinician after proper assessment.

Side effects

What you might experience.

The Wegovy Tablet has the GLP-1 class side-effect profile — most are gastrointestinal, most common when starting or increasing dose, and usually settle over a few weeks. This isn't exhaustive — always read the patient information leaflet provided with your medicine.

Common

Affects > 1 in 10
  • Nausea
  • Diarrhoea
  • Constipation
  • Vomiting
  • Decreased appetite
  • Fatigue

Uncommon

1 in 100 to 1 in 10
  • Dizziness
  • Abdominal pain or discomfort
  • Burping or bloating
  • Hair loss
  • Gallstones
  • Hypoglycaemia (with type 2 diabetes)

Serious but rare

Seek medical attention
  • Severe allergic reaction
  • Acute pancreatitis
  • Severe hypoglycaemia
  • Gallbladder disease
  • Worsening diabetic retinopathy
!

Report any side effect. Tell your clinician and report it via the MHRA Yellow Card scheme — this helps the MHRA monitor the safety of all medicines.

Eligibility

Who can — and can't — take this.

The Wegovy Tablet is a powerful licensed medicine, and like any powerful medicine it isn't right for everyone. Your clinician assesses your full history during consultation.

The tablet may be suitable if you…

  • Are aged 18 or over
  • Have a BMI of 30+ (obesity)
  • Have a BMI of 27–30 with a weight-related condition (e.g. type 2 diabetes, high blood pressure, sleep apnoea)
  • Can take a tablet once a day on an empty stomach as directed
  • Are ready to support treatment with diet and activity changes

The tablet is not suitable if you…

  • Are pregnant, planning pregnancy, or breastfeeding
  • Have type 1 diabetes
  • Have a personal/family history of medullary thyroid carcinoma or MEN2
  • Have a history of pancreatitis
  • Have severe gastrointestinal disease (e.g. gastroparesis)
  • Have an active eating disorder
  • Have severe liver or kidney impairment (case-by-case)
  • Are allergic to semaglutide or any excipient

These lists aren't exhaustive — your clinician reviews your full medical history and current medicines before prescribing.

Transparent pricing

One monthly price. Clearly priced.

Your monthly price covers the medication. New patients start on the 1.5mg dose and step up under clinical supervision — no subscription lock-ins and no hidden fees.

DoseStagePrice / mo*
1.5mgStarter dose£115
4mgTitration dose£130
9mgTitration dose£145
25mgMaximum licensed dose£190

* Standard monthly prices shown. You always see the exact price for your dose, including tracked delivery, before you pay. In stock now — dispatched with discreet, tracked next-day delivery.

Compare treatments

Prefer an injection, or want to compare?

Explore the alternatives, or start the free check and your prescriber recommends the best fit for you.

Mounjaro (tirzepatide) Wegovy injection Compare all treatments
Good to know

Wegovy Tablet questions.

The things patients most often ask before starting. Still unsure? Our pharmacy team is happy to help.

Check your eligibility
How is the Wegovy Tablet different from the Wegovy injection?
It is the same active ingredient — semaglutide — taken as a once-daily tablet instead of a once-weekly injection. Both act on the GLP-1 receptor to reduce appetite. The tablet suits people who would prefer not to inject.
How do I take the Wegovy Tablet?
One tablet daily, first thing on an empty stomach with a small sip of plain water (no more than 120 ml), then wait at least 30 minutes before eating, drinking or taking other medicines. Taken with food it is far less effective.
How much does the Wegovy Tablet cost?
From £115 a month (1.5mg starter dose). Higher maintenance doses are £130–£190 a month.

Start with the eligibility check.

Free consultation, reviewed by a UK-registered clinician. No card required to start.

Check eligibility